but Genway and AMDL only sold it for lab use (other than CRC monitoring).
Gartner wants to sell it to the masses as a lung cancer screener. I can almost guarantee the FDA will shut him down.
You'd think the FDA would allow DNA testing -- 23andMe certainly assumed so. If the FDA cracked down on DNA tests, they most certainly will crack down on cancer screening tests.
I realize that DR-70 is not a valid cancer screener. I think Gartner knows it too. MacLellan certainly knows it - he admitted that in a conference call, as you know. But that doesn't matter. If Gartner gest funding, he will start up GCDx. Gartner is 72 years old. I don't think he cares whether he ever sells a DR-70 test as long as he gets a couple years' salary out of GCDx. Call me cynical, but that is my opinion.
I don't think the FDA will allow DR-70 under its Home Brew designation. I could be wrong. And actually I don't think it really matters because I don't think GCDx revenues will amount to much -- if a potential customer asks their doctor first, the doctor will say "don't buy that test," IMO. So it really won't matter much whether the FDA shuts Gartner down or not, IMO.
There isn't anything else to talk about. Apparently, MacLellan will never file for bankruptcy. Sheesh. I can't understand why the lenders allow this zombie status. Seems like they couldn't write off the full loss until Radient goes BK.
